| dc.contributor.author | Smith, Sinead | en |
| dc.date.accessioned | 2016-07-08T10:40:40Z | |
| dc.date.available | 2016-07-08T10:40:40Z | |
| dc.date.issued | 2016 | en |
| dc.date.submitted | 2016 | en |
| dc.identifier.citation | O'Morain C, Smith S, Heliocbacter pylori treatment failure: the rationale for alternative antibiotics, Digestion, 93, 4, 2016, 309 - 310 | en |
| dc.identifier.other | Y | en |
| dc.description | PUBLISHED | en |
| dc.format.extent | 309 | en |
| dc.format.extent | 310 | en |
| dc.language.iso | en | en |
| dc.relation.ispartofseries | Digestion | en |
| dc.relation.ispartofseries | 93 | en |
| dc.relation.ispartofseries | 4 | en |
| dc.rights | Y | en |
| dc.title | Heliocbacter pylori treatment failure: the rationale for alternative antibiotics | en |
| dc.type | Journal Article | en |
| dc.type.supercollection | scholarly_publications | en |
| dc.type.supercollection | refereed_publications | en |
| dc.identifier.peoplefinderurl | http://people.tcd.ie/smithsi | en |
| dc.identifier.rssinternalid | 115737 | en |
| dc.identifier.doi | https://doi.org/10.1159/000444362 | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.subject.TCDTheme | Immunology, Inflammation & Infection | en |
| dc.identifier.orcid_id | 0000-0003-3460-3590 | en |
| dc.identifier.uri | http://hdl.handle.net/2262/76664 | |
